Source: Virtual Congress 2020 – Translational science in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. LENEVA (Moscow, Russian Federation), I. Falynskova (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria). Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia. 2338

Member's Comments

No comment yet.

Related content which might interest you: Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Long-term outcomes after viral pneumonia caused by influenza A (H1N1) Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002 Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation Source: Eur Respir J 2011; 37: 44-52 Year: 2011 Bacterial coinfections in swine influenza (H1N1) pneumonia Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Role of influenza virus infection in lung fibrosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 RNA interference against influenza A (H1N1) virus Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic Source: Eur Respir J 2011; 37: 106-111 Year: 2011 Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011 Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Oral presentation: The long-term effect of neonatal respiratory syncytial virus (RSV) infection on the response to adult allergen challenge Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Serial viral infections in infants with recurrent respiratory illnesses Source: Eur Respir J 2008; 32: 314-320 Year: 2008 Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients Source: Annual Congress 2011 - Lung transplantation Year: 2011 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Impaired viral clearance after influenza infection in IDO transgenic mice Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019